The inhibition of ccl4-induced liver fibrosis by TIM-4 is achieved through interference with KCs via the Akt4/mitophagic signaling pathway, and it also delays the progression of NAFLD. This evidence concerns the gene CCL4 and metabolic dysfunction-associated steatotic liver disease.